“Roswell Park Cancer Institute Genomic Sequencing Test Wins New York State Approval,” Roswell Park Cancer Institute

The New York State Department of Health (DOH) has granted Roswell Park Cancer Institute approval to begin genomic testing of cancer patients using its OmniSeq TargetTM advanced molecular diagnostic laboratory test. Roswell Park Cancer Institute is one of the 25 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news